Table 3.
Test results with the reference substance azadirachtin
| Test | Emergence rate | Development time | %MDD | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CV in SC [%] | NOEC | LOEC | EC50 (95% CI) | CV in SC [%] | NOEC | LOEC | EC10 (95% CI) | ||
| RFT | 5.2 | 25 | 125 | 160 (132–188) | 2.7 | 25 | 125 | 6.19 (0–36.5) | 10.5–11.2 |
| CRT1 | 10.0 | 74 | 148 | 565 (413–717) | 3.1 | < 37 | ≤ 37 | 79.5 (78.8–238) | 4.0–4.2 |
| CRT2 | 22.5 | < 37 | ≤ 37 | 88.6 (72.3–105) | 4.8 | < 37 | ≤ 37 | 18.7 (7.60–29.9) | 5.7–6.1 |
RFT range-finding test, CRT concentration–response test, CV coefficient of variation, SC solvent control, NOEC no-observed-effect concentration, LOEC lowest-observed-effect concentration, ECx X % effective concentration, CI confidence interval, MDD minimum detectable difference